238 related articles for article (PubMed ID: 30165904)
1. Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JMW; Robertson JF; Ellis IO; Nicholson RI
Breast Cancer Res; 2018 Aug; 20(1):98. PubMed ID: 30165904
[TBL] [Abstract][Full Text] [Related]
2. Correction to: The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2020 Jan; 179(2):521-522. PubMed ID: 31655919
[TBL] [Abstract][Full Text] [Related]
3. Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
Breast Cancer Res; 2018 Jul; 20(1):68. PubMed ID: 29986739
[TBL] [Abstract][Full Text] [Related]
4. Correction: RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin.
Hwang MH; Cho KH; Jeong KJ; Park YY; Kim JM; Yu SL; Park CG; Mills GB; Lee HY
Oncogene; 2019 May; 38(20):3970-3971. PubMed ID: 30679788
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2018 Jul; 20(1):63. PubMed ID: 29966525
[TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
Chen C; Chang YC; Lan MS; Breslin M
Int J Oncol; 2016 Aug; 49(2):847. PubMed ID: 27279381
[TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.
Fujise Y; Okano J; Nagahara T; Abe R; Imamoto R; Murawaki Y
Int J Oncol; 2016 Sep; 49(3):1259. PubMed ID: 27314753
[TBL] [Abstract][Full Text] [Related]
8. Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
Cell Death Dis; 2019 Jun; 10(7):501. PubMed ID: 31235854
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: 2600-years of stratospheric volcanism through sulfate isotopes.
Gautier E; Savarino J; Hoek J; Erbland J; Caillon N; Hattori S; Yoshida N; Albalat E; Albarede F; Farquhar J
Nat Commun; 2019 Jun; 10(1):2663. PubMed ID: 31209219
[TBL] [Abstract][Full Text] [Related]
10. Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
BMC Cancer; 2018 Oct; 18(1):1047. PubMed ID: 30373551
[TBL] [Abstract][Full Text] [Related]
11. Correction to: Development of a novel strategy for fungal transformation based on a mutant locus conferring carboxin-resistance in Magnaporthe oryzae.
Guo M; Zhu X; Li H; Tan L; Pan Y
AMB Express; 2019 Jun; 9(1):96. PubMed ID: 31254121
[TBL] [Abstract][Full Text] [Related]
12. Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
Oncogene; 2020 Mar; 39(10):2224-2226. PubMed ID: 31819168
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing.
Wang J; Morita Y; Han B; Niemann S; Löffler B; Rudolph KL
Nat Cell Biol; 2019 Jun; 21(6):791-792. PubMed ID: 30808996
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Guttery DS; Hancox RA; Mulligan KT; Hughes S; Lambe SM; Howard Pringle J; Walker RA; Louise Jones J; Shaw JA
Breast Cancer Res; 2018 Aug; 20(1):80. PubMed ID: 30068377
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Culex pipiens crossing type diversity is governed by an amplified and polymorphic operon of Wolbachia.
Bonneau M; Atyame C; Beji M; Justy F; Cohen-Gonsaud M; Sicard M; Weill M
Nat Commun; 2018 Apr; 9(1):1491. PubMed ID: 29643367
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] NLRP3 inflammasome is responsible for Hantavirus inducing interleukin‑1β in THP‑1 cells.
Ye W; Lei Y; Yu M; Xu Y; Cao M; Yu L; Zhang L; Li P; Bai W; Xu Z; Zhang F
Int J Mol Med; 2019 Jun; 43(6):2533. PubMed ID: 30942435
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
Oncol Rep; 2018 Apr; 39(4):2051. PubMed ID: 29484410
[TBL] [Abstract][Full Text] [Related]
19. Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2016 Apr; 156(2):403-4. PubMed ID: 26960710
[TBL] [Abstract][Full Text] [Related]
20. Correction to: Different apoptotic effects of saxifragifolin C in human breast cancer cells.
Kim KH; Kim JY; Kwak JH; Kim BO; Pyo S
Arch Pharm Res; 2019 Apr; 42(4):373-374. PubMed ID: 30467625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
